Forbion Capital Fund IV Cooperatief U.A. 的 Form 4 申報
NewAmsterdam Pharma Co N.V.（NAMS），2024/12/18 申報
- 申報編號
- 0000950170-24-137893
- 申報時間
- 2024/12/18 16:15 ET
- 交易日
- 2024/12/16-12/17
- 申報延遲
- 2 天
- 10b5-1 計畫
- 有勾選
這份申報列了 3 筆非衍生性交易。公開市場賣出合計 $299.6 萬。交易後 2 天申報。
申報人
一份 Form 4 可以有好幾位申報人，例如本人與他控制的基金。各交易表上顯示的是第一位。
| 申報人 | 與公司的關係 |
|---|---|
| Forbion Capital Fund IV Cooperatief U.A.CIK 0001823747 | 持股 10% 以上大股東 |
| Forbion Growth Opportunities Fund I Cooperatief U.A.CIK 0001911047 | 持股 10% 以上大股東 |
| Forbion Growth Management B.V.CIK 0001918318 | 持股 10% 以上大股東 |
| Forbion IV Management B.V.CIK 0002005384 | 持股 10% 以上大股東 |
| ForGrowth NAP B.V.CIK 0002005407 | 持股 10% 以上大股東 |
非衍生性證券（表 I）
普通股等股票的取得與處分，每一列是申報上的一筆。
附註與備註
本站收錄交易價格引用的附註、修正申報（Form 4/A）的全部附註，以及申報的備註。其他附註，例如間接持有的方式、交易計畫的細節，請看 SEC EDGAR 上的原文。
- F4
Represents 29,272 shares sold on behalf of Forbion Growth I and 37,376 shares sold on behalf of Forbion IV. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $25.00 to $25.99. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Following the reported transaction, of the 11,056,966 Ordinary Shares beneficially owned by ForGrowth, 652,173 shares are directly owned by ForGrowth on behalf of Forbion Growth I, and 10,404,793 are held by PoolCo and are allocated to ForGrowth, of which 4,203,740 shares are beneficially owned by Forbion Growth I and 6,201,053 shares are beneficially owned by Forbion IV.
表 I 有 1 筆交易的價格引用這則附註。
- F5
Represents 20,966 shares sold on behalf of Forbion Growth I and 26,770 shares sold on behalf of Forbion IV. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $26.00 to $25.855. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Following the reported transaction, of the 11,009,230 Ordinary Shares beneficially owned by ForGrowth, 652,173 shares are directly owned by ForGrowth on behalf of Forbion Growth I, and 10,357,057 are held by PoolCo and are allocated to ForGrowth, of which 4,182,774 shares are beneficially owned by Forbion Growth I and 6,174,283 shares are beneficially owned by Forbion IV.
表 I 有 1 筆交易的價格引用這則附註。